MedTrace Logo

The COVID-19 Mobile Health Study (CMHS)

NCT04275947 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2020-02-19

No results posted yet for this study

Summary

This study evaluates a brand-new cell phone-based auto-diagnosis system, which is based on the clinical guidelines, clinical experience, and statistic training model. We will achieve secure and 1st hand data from physicians in Wuhan, which including 150 cases in the training cohort and 300 cases in the validation cohort.

Conditions

Interventions

OTHER

nCapp, a cell phone-based auto-diagnosis system

Combined with 15 questions online, and a predicated formula to auto-diagnosis of the risk of COVID-19

Sponsors & Collaborators

  • Shanghai Respiratory Research Institution

    collaborator UNKNOWN

  • Chinese Alliance Against Lung Cancer

    lead OTHER

Principal Investigators

  • Chunxue Bai · Shanghai Respiratory Research Institution

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-14
Primary Completion
2020-04-30
Completion
2020-05-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04275947 on ClinicalTrials.gov